December, 22 2025 Monday 09:03 Hrs
Last update 11-9-2025
  • SENSEX :   84,929.36

  • Top commodity trading and broking companies in India0.00( 0.00%) 19-Dec-2025

IPO Synopsis

Nephrocare Health Services Ltd
  • Registered Office: 5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64, Hyderabad - 500081, Telangana, India.
  • Phone : +91 40 4240 8039   Fax:
  • Email : cs@nephroplus.com
  • Website :www.nephroplus.com
Initial public offering of 18,943,020 equity shares of face value of Rs.2/- each ("equity shares") of Nephrocare Health Services Limited ("the company" or the "company" or the "issuer") for cash at a price of Rs.460/- per equity share face value of Rs.2/- (including a securities premium of Rs.458/- per equity share) ("offer price") aggregating to Rs.871.05 crores ("offer") comprising a fresh issue of 7,690,162 equity shares of face value of Rs.2/- each aggregating to Rs.353.41 crores ("fresh issue") and an offer for sale of 11,253,102 equity shares of face value of Rs.2/- each ("offered shares") aggregating to Rs.517.64 crores , comprising an offer for sale of 1,521,728 equity shares of face value of Rs.2/- each aggregating to Rs.70.00 crores by Investcorp Private Equity Fund II and 1,604,907 equity shares of face value of Rs.2/- each aggregating to Rs.73.83 crores by Healthcare Parent Limited and 147,765 equity shares of face value of Rs.2/- each aggregating to Rs.6.80 crores by Investcorp Growth Opportunity Fund and 2,888,911 equity shares of face value of Rs.2/- each aggregating to Rs.132.89 crores by Edoras Investment Holdings Pte. Ltd. ("promoter selling shareholders") and 121,985 equity shares of face value of Rs.2/- each aggregating to Rs.5.61 crores by Investcorp India Private Equity Opportunity Limited and 3,089,663 equity shares of face value of Rs.2/- each aggregating to Rs.142.12 crores by International Finance Coproration and 1,433,468 equity shares of face value of Rs.2/- each aggregating to Rs.65.94 crores by 360 One Special Opportunities Fund - Series 9 and 444,675 equity shares of face value of Rs.2/- each aggregating to Rs.20.46 crores by 360 One Special Opportunities Fund - Series 10 ("other selling shareholders" and together with the promoter selling shareholders, the "selling shareholders" and such offer for sale by the selling shareholders, the "offer for sale"). The offer constituted 18.88% of the post-offer paid-up equity share capital of the company.
Issue
Opens On Closes On
10-Dec-25 12-Dec-25
Money Payable On
Application Allotment
460.00 0.00
Minimum Application for shares in Nos : 32 Further Multiples of : 32
(.Cr) Lead Managers to the Issue
Project Cost (.Cr) 325.15 Ambit Private Limited
Project Financed through Current Offer (.Cr) 871.05  
Post Issue Equity Share Capital (.Cr) 20.07
Issue Price () 460.00
Projects
Capital expenditure by our Company for opening new dialysis clinics in India
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
General corporate purposes
Promoted By
Vikram Vuppala
Bessemer Venture Partners Trus
Edoras Investment Holdings Pte
Listing At
BSE
NSE
Registrar to the Issue
KFin Techologies Ltd
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.